Stay updated with breaking news from Multicenter Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
12.09.2022 - Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced the presentation of data supporting the potential of omidubicel ... Seite 1
This observational follow-up study of patients from the MOMENTUM 3 randomized trial compares outcomes and overall survival in individuals who received a fully m
New research presented today at the Society of NeuroInterventional Surgery's (SNIS) 19th Annual Meeting shows that thrombectomy, a minimally invasive procedure typically reserved for treating a severe type of stroke known as large vessel occlusions (LVO), achieves positive outcomes for individuals experiencing other types of strokes.
STOCKHOLM, June 24, 2022 /PRNewswire/ -- Sobi will present new data at ISTH 2022, the 30th Congress of the International Society on Thrombosis and Haemostasis, taking place online and in London
Gilead and Kite Oncology to present latest blood cancer research at the European Hematology Association (EHA) 2022 CongressSub-analyses from Kite’s ZUMA-7 study of CAR T cell therapy in second-line diffuse large B cell lymphoma includes data in patients over 65 and by tumour burden characteristicsLonger-term d...